Market Tracker

07/23 6:05pm ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

6.91
Data as of Jul 23
 +0.08 / +1.17%
Today’s Change
2.26
Today|||52-Week Range
8.61
+108.20%
Year-to-Date

Today’s Trading

Previous close6.83
Today’s open6.92
Day’s range6.84 - 7.12
Volume2,660,312
Average volume (3 months)6,397,989
Market cap$661.1M
Dividend yield--
Data as of 3:59pm ET, 07/23/2014

Growth & Valuation

Earnings growth (last year)+1.56%
Earnings growth (this year)-20.80%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book4.32

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc0.000.00%
OMEDOncoMed Pharmaceutic...+2.18+9.93%
SAGESAGE Therapeutics In...-0.09-0.33%
ANACAnacor Pharmaceutica...+0.50+3.04%
Data as of 4:04pm ET, 07/23/2014

Financials

Next reporting dateAugust 6, 2014
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$58.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Head-Investor Relations
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts